Showing results (51-60 of 166) with videos related to
Sort By:
Pageof 17
Journal of Vascular and Interventional Radiology : JVIR|June 21, 2018
First-in-Man Experience with a Novel Catheter-Based Renal Denervation System of Ultrasonic Ablation in Patients with Resistant HypertensionGil Chernin, Iris Szwarcfiter, Dierk Scheinert, et al.Acta Cardiologica|November 3, 2022
Trends and outcomes in transcatheter aortic valve implantation in Belgium: a 13-year single centre experienceAndrea Bezzeccheri, Paul Vermeersch, Stefan Verheye, et al.Journal of the American College of Cardiology|December 19, 2006
Randomized double-blind comparison of sirolimus-eluting stent versus bare-metal stent implantation in diseased saphenous vein grafts: six-month angiographic, intravascular ultrasound, and clinical follow-up of the RRISC TrialPaul Vermeersch, Pierfrancesco Agostoni, Stefan Verheye, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|December 27, 2017
Long-term clinical outcomes of a crystalline sirolimus-eluting coronary stent with a fully bioabsorbable polymer coating: five-year outcomes from the DESSOLVE I and II trialsWilliam Wijns, Mathias Vrolix, Stefan Verheye, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|December 15, 2020
Coronary sinus narrowing for the treatment of refractory angina: a multicentre prospective open-label clinical study (the REDUCER-I study)Stefan Verheye, Pierfrancesco Agostoni, Francesco Giannini, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 15, 2015
DESyne novolimus-eluting coronary stent is superior to Endeavor zotarolimus-eluting coronary stent at five-year follow-up: final results of the multicentre EXCELLA II randomised controlled trialJavaid Iqbal, Stefan Verheye, Alexandre Abizaid, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 13, 2016
Safety and performance of the DRug-Eluting Absorbable Metal Scaffold (DREAMS) in patients with de novo coronary lesions: 3-year results of the prospective, multicentre, first-in-man BIOSOLVE-I trialMichael Haude, Raimund Erbel, Paul Erne, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|August 20, 2014
A first-in-man clinical evaluation of Ultimaster, a new drug-eluting coronary stent system: CENTURY studyEmanuele Barbato, Sonja Salinger-Martinovic, Dragan Sagic, et al.Cardiovascular Revascularization Medicine : Including Molecular Interventions|October 20, 2023
In-vitro validation of coronary physiology assessment with 5 French guiding cathetersAlice Benedetti, Gianluca Castaldi, Enrico Poletti, et al.International Journal of Cardiology|November 25, 2019
Five-year clinical outcome of multicenter randomized trial comparing amphilimus - with paclitaxel-eluting stents in de novo native coronary artery lesionsDidier Carrié, Jacques Berland, Stefan Verheye, et al.Pageof 17